Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro

Journal of Interferon and Cytokine Research

Volumn 18, Issue 10, 1998, Pages 889-895

  Bozza, Mary ^a   Kyvelos, Dimitrios ^b   Trepicchio, William L ^a   Collins, Mark ^a   Klempner, Mark S ^b   Dorner, Andrew J ^a  

^a PFIZER INC   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; PHORBOL 12 ACETATE 13 MYRISTATE; RECOMBINANT INTERLEUKIN 11; ZYMOSAN;

ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOREGULATION; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031740586     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.889     Document Type: Article

References (24)

1. SMITH, J.A. (1994). Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56, 672-686.
2. BAZZONI, F., CASSATELLA, M.A., ROSSI, F., CESKA, M., DEWALD, B., and BAGGIOLINI, M. (1991). Phagocytosing neutrophils produce and release high amounts of neutrophil-activating peptide 1/interleukin 8. J. Exp. Med. 173, 771-774.
3. CASSATELLA, M.A. (1995). The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16, 21-26.
4. CASSATELLA, M.A., MEDA, L., BONARA, S., CESKA, M., and CONSTANTIN, G. (1993). IL-10 inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178, 2207-2211.
5. MULLEN, P.G., WINDSOR, A.C.J., WALSH, C.J., FOWLER, A.A., and SUGERMAN, H.J. (1995). Tumor necrosis factor-α and interleukin-6 selectively regulate neutrophil function in vitro. J. Surg. Res. 58, 124-130.
6. DU, X.X., and WILLIAMS, D.A. (1997). Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89, 3897-3908.
7. TAGA, T., YOSHIDA, K., HIROTA, H., and KISHIMOTO, T. (1996). Physiological and pathological role or gp130, a common signal transducer for IL-6 family of cytokines. In: Bone Marrow Transplant: Basic and Clinical Studies. S.I. Kehara, F. Takaku, and R.A. Good (eds.) Tokyo: Springer-Verlag, pp. 101-109.
8. GOLDMAN, S.J. (1995). Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells 13, 462-471.
9. TEPLER, I., EKIAS, L., SMITH, J.W., HUSSEIN, M., ROSEN, G., SHANG, A.Y.-C., MOORE, J.O., GORDON, M.S., KUCA, B., BEACH, K.J., LOEWY, J.W., GARNICK, M., and KAYE, J.A. (1996). A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87, 3607-3614.
10. GORDON, M.S., McCASKILL-STEVENS, W.J., BATTIATO, L.A., LOEWY, J., LOESCH, D., BREEDEN, E., HOFFMAN, R., BEACH, K.J., KUCA, B., KAYE, J., and SLEDGE, G.W. (1996). A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87, 3615-3624.
11. TREPICCHIO, W.L., BOZZA, M., PEDNAULT, G., and DORNER, A.J. (1996). Recombinant human interleukin-11 attenuates the inflammatory response through downregulation of proinflammatory cytokine release and nitric oxide production. J. Immunol. 157, 3627-3634.
12. REDLICH, C.A., GAO, X., ROCKWELL, S., KELLY, M., and ELIAS, J.A. (1996). IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J. Immunol. 157, 1705-1710.
13. TREPICCHIO, W.L., WANG, I., BOZZA, M., and DORNER, A.J. (1997). Interleukin-11 regulates macrophage effector function through the inhibition of NF-κB. J. Immunol. 159, 5661-5670.
14. KEITH, J.C., ALBERT, A., SONIS, S.T., PFEIFFER, C.J., and SCHAUB, R.G. (1994). IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 12 (Suppl 1), 79-90.
15. QIU, B., PFEIFFER, C.J., and KEITH, J.C. (1996). Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig. Dis. Sci. 41, 1625-1630.
16. KLEMPNER, M.S., and GALLIN, J.I. (1978). Separation and functional characterization of human neutrophil subpopulations. Blood 51, 659.
17. Klempner, M.S., DINARELLO, C.A., and GALLIN, J.I. (1978). Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J. Clin. Invest. 61, 1330-1336.
18. KLEMPNER, M.S., DINARELLO, C.A., HENDERSON, W.R., and GALLIN, J.I. (1979). Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J. Clin. Invest. 64, 996-1002.
19. HILTON, A.A., RAICEVIC, A., RAKAR, S., HARRISON-SMITH, M., GOUGH, N.M., BEGLEY, C.G., METCALF, D., NICOLA, N.A., and WILLSON, T.A. (1994). Cloning of a murine IL-11 receptor α chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13, 4765-4775.
20. GANZ, T., and LEHRER, R.I. (1997). Antimicrobial peptides of leukocytes. Curr. Opin. Hematol. 4, 53-58.
21. SHALABY, M.R., AGGARWAL, B.B., RINDERKNECHT, E., SVEDERSKY, L.P., FINKLE, B.S., and PALLADINO, M.A. (1985). Activation of human polymorphonuclear neutrophil functions by IFNγ and TNFs. J. Immunol. 135, 2069.
22. TURNER, K., and CLARK, S. (1995). Interleukin-11: biological and clinical perspectives. In: Hematopoietic Growth Factors in Clinical Applications. R. Mertlsmann and F. Hermann (eds.) New York: Marcel Dekker, pp. 315-336.
23. MULLEN, P.G., WINDSOR, A.C.J., WALSH, C.J., FOWLER, A.A., and SUGERMAN, H.J. (1995). Tumor necrosis factor-α and IL-6 selectively regulate neutrophil function in vitro. J. Surg. Res. 58, 124-130.
24. OPAL, S.M., JHUNG, J.W., KEITH, J.C., STOUPIS, A., PALARDY, J.E., PAREJO, N.A., YOUNG, L.D., and BHATTACHARJEE, A. (1998). Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocomprised animals. J. Infect. Dis. 178, 1205-1208.